首页 > 期刊杂志 > 正文

Thyroid Pathology Findings in Cowden Syndrome: A Clue for the Diagnosis of the PTEN Hamartoma Tumor Syndrome.

Cowden综合症中甲状腺病理表现是PTEN错构瘤综合症的诊断线索

Cameselle-Teijeiro J,Fachal C,Cabezas-Agrícola JM,Alfonsín-Barreiro N,Abdulkader I,Vega-Gliemmo A,Hermo JA

Abstract

PTEN hamartoma tumor syndrome (PHTS) is a hereditary disorder caused by germline inactivating mutations of the PTEN gene. PHTS includes Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. We describe how the peculiar pathologic and immunohistochemical thyroid features lead pathologists to suggest PHTS.
A 28-year-old white Spanish woman had a multinodular goiter. Total thyroidectomy was performed after fine-needle aspiration biopsy. Microscopic, immunohistochemical, and molecular analyses of the thyroid lesions were realized.
The thyroid was multinodular, showing one papillary microcarcinoma, five follicular adenomas, three adenolipomas, 46 tiny adenomatous nodules (microadenomas), scattered foci of adipose tissue, and lymphocytic thyroiditis. Tumors were positive for thyroglobulin, thyroperoxidase, pendrin, cyclin D1, and p27 but negative for calcitonin and PTEN. A germline heterozygous deletion of one adenine at nucleotide 827 in exon 8 of the PTEN gene was confirmed. No BRAF, NRAS, or KRAS somatic mutations were detected in the papillary microcarcinoma, follicular adenoma, adenolipomas, or microadenomas. Negativity for PTEN was also found in the colonic tubulovillous adenoma and the storiform collagenoma.
Pathologists play a crucial role in recognizing pathologic thyroid findings associated with PHTS for selecting patients for genetic testing.

摘要

PTEN错构瘤综合症(PHTS)是一种因PTEN基因发生胚系失活突变引起的遗传性疾病。PHTS包括Cowden

综合症、Bannayan-Riley-Ruvalcaba综合症。本文研究甲状腺肿提示病理学家诊断PHTS的病理和免疫组化独特之处。

一名28岁西班牙白人结节性甲状腺肿女患者,细针穿刺活检后行全甲状腺切除术。对其甲状腺病变进行镜下组织病理学、免疫组化及分子分析。

甲状腺呈多结节状,显示有一个乳头状微癌病灶、5个滤泡性腺瘤、3个腺脂肪瘤、46个小腺瘤样结节(微腺瘤)、局灶散在分布脂肪组织以及淋巴细胞性甲状腺炎。免疫组化显示TG(甲状腺球蛋白)、TPO(甲状腺过氧化物酶)、pendrin、cyclin D1和p27阳性, 降钙素(calcitonin)和PTEN阴性。分子分析证实PTEN基因8号外显子第827个核苷酸的一个腺嘌呤发生胚系杂合性缺失。乳头状微癌、滤泡性腺瘤、腺脂肪瘤或微腺瘤中未检测到BRAF、NRAS或KRAS体细胞突变。结肠管状绒毛状腺瘤和硬化性纤维瘤中免疫组化也显示PTEN阴性。

识别PHTS相关甲状腺病理性改变,筛选出患者进一步做基因检测,病理学家在此发挥着重要作用。

full text

我要评论

0条评论